antibiotics
| 7 min read
The NIH budget survived a proposed 40 percent cut, but falling grant numbers could still have lasting consequences for drug discovery.
| 3 min read
A new intravaginal drug delivery platform has been selected to investigate whether localized UTI treatment can reduce the collateral effects of systemic antibiotics.
| 5 min read
The approach identifies entirely new chemical structures that could help replenish a thinning antibiotic pipeline as resistance continues to rise.
| 4 min read
Billion-dollar partnerships, Phase 1 wins, AI regulatory tools, and more led the news this week.
| 6 min read
A century after the first vaccine, tuberculosis still claims over a million lives a year, but promising research could change the story.
| 4 min read
Another biotech retreats from AAV, a promising antibiotic, a paused CRISPR trial, and more led the news this week.
| 4 min read
Researchers are turning bacterial transport systems from obstacles into opportunities for targeted therapy.
| 2 min read
Nearly 25 percent of non-antibiotic drugs tested in the study enabled the proliferation of enteropathogens.
| 2 min read
Real-world data and KOL insights highlight MeMed BV’s supportive role in emergency medicine
| 3 min read
After decades of stalled innovation, a new oral antibiotic could now combat both everyday infections and urgent public health threats.
